Non-surgical treatment for people who have suffered a more severe form of haemorrhagic stroke could be on the cards if trials here and in the United States prove successful.
Researchers are testing a protein-based compound that reduces inflammation in the brain after injury. It would complement existing treatment for the affliction, which makes up about one-fifth of all stroke cases here but caused 44 per cent of all stroke-related deaths in 2016.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
- Latest headlines and exclusive stories
- In-depth analyses and award-winning multimedia content
- Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*
*Terms and conditions apply.